Erin L. Marcotte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erin L. Marcotte has a total of 228 co-authors. Here are the top co-authors by number of shared publications:
- Michael E. Scheurer
Emory University School of Medicine, Atlanta, Georgia, United States
43 shared publications - Logan G. Spector
Department of Pediatrics, University of Minnesota, Minneapolis, USA
41 shared publications - Eve Roman
Epidemiology and Cancer Statistics Group, Department of Health Sciences University of York York UK
28 shared publications - Jenny N. Poynter
Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
27 shared publications - Nathan Pankratz
Department of Laboratory Medicine and Pathology, School of Medicine, University of Minnesota, Minneapolis, USA
27 shared publications - Aurora Castellano
13Department of Pediatric Hematology-Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
25 shared publications
Latest Publications
- 21 August 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 104, 103208
The Childhood Cancer and Leukemia International Consortium (CLIC): Expanding global collaboration in pediatric cancer etiology research
- 21 August 2026
- Published by Elsevier in Cancer Epidemiology
- Vol. 104, 103208
The Childhood Cancer and Leukemia International Consortium (CLIC): Expanding global collaboration in pediatric cancer etiology research
- Open Access
- 30 December 2025
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (1) , 82-100
The Unique Utility of Newborn Dried Blood Spots for Driving Discovery in Childhood Cancer Research
Background: Childhood cancer, though rare, remains the leading cause of disease-related death among children in the United States. The overall incidence has been rising for the past several decades, and the factors underlying the increasing rates are unclear. This unexplained increase underscores the critical need for high-quality, well-powered epidemiologic research to elucidate causes and the natural history of childhood cancers. Content: Newborn screening (NBS) utilizes dried blood spots collected soon after birth to identify serious, treatable conditions and enable timely intervention, testing over 98% of infants born in the United States annually. Some NBS programs allow for the retention and release of residual dried blood spots (rDBS) for research. rDBS enable population-based assessment of both endogenous and exogenous factors, including genetic, epigenetic, metabolic, immune characteristics, and environmental exposures during the perinatal period. This resource can overcome challenges of recall bias, exposure misclassification, and the impracticality of prospective cohort studies for rare cancers. Investigators have successfully used rDBS in epidemiologic studies, substantially advancing knowledge of several types of childhood cancers. Despite variability in storage and analyte stability, rDBS remain an invaluable resource to promote child health and constitute the only widely available prediagnostic biospecimen source for studies of childhood cancers. Summary: rDBS from NBS programs represent a population-based, widely collected, prediagnostic biospecimen to investigate genetic, epigenetic, metabolic, and immune pathways underlying childhood cancer. Despite variability in storage policies, rDBS offer an unparalleled resource to advance etiologic understanding. Their integration into research could transform knowledge of childhood cancer causes and inform strategies for prevention and surveillance.
- 30 December 2025
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (1) , 82-100
Open AccessThe Unique Utility of Newborn Dried Blood Spots for Driving Discovery in Childhood Cancer Research
Background: Childhood cancer, though rare, remains the leading cause of disease-related death among children in the United States. The overall incidence has been rising for the past several decades, and the factors underlying the increasing rates are unclear. This unexplained increase underscores the critical need for high-quality, well-powered epidemiologic research to elucidate causes and the natural history of childhood cancers. Content: Newborn screening (NBS) utilizes dried blood spots collected soon after birth to identify serious, treatable conditions and enable timely intervention, testing over 98% of infants born in the United States annually. Some NBS programs allow for the retention and release of residual dried blood spots (rDBS) for research. rDBS enable population-based assessment of both endogenous and exogenous factors, including genetic, epigenetic, metabolic, immune characteristics, and environmental exposures during the perinatal period. This resource can overcome challenges of recall bias, exposure misclassification, and the impracticality of prospective cohort studies for rare cancers. Investigators have successfully used rDBS in epidemiologic studies, substantially advancing knowledge of several types of childhood cancers. Despite variability in storage and analyte stability, rDBS remain an invaluable resource to promote child health and constitute the only widely available prediagnostic biospecimen source for studies of childhood cancers. Summary: rDBS from NBS programs represent a population-based, widely collected, prediagnostic biospecimen to investigate genetic, epigenetic, metabolic, and immune pathways underlying childhood cancer. Despite variability in storage policies, rDBS offer an unparalleled resource to advance etiologic understanding. Their integration into research could transform knowledge of childhood cancer causes and inform strategies for prevention and surveillance.
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results–Based Analysis
Supplementary Table from The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results–Based Analysis
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table from The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results–Based Analysis
Supplementary Table from The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results–Based Analysis
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Data from The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results–Based Analysis
Background:Recent investigations of malignant peripheral nerve sheath tumor (MPNST) survival have reported higher mortality among non-White individuals. However, previous analyses have not examined the impact of socioeconomic status (SES) on these observations. This study aims to characterize factors associated with cause-specific MPNST survival, including information related to census-tract-level SES (CT-SES).Methods:We identified 2,432 primary MPNSTs using the Surveillance, Epidemiology, and End Results (SEER) 18 (2000–2016) database. We used Cox proportional hazards modeling to estimate the effects of sex, race/ethnicity, CT-SES quintile, metastasis at diagnosis, tumor site, age at diagnosis, and treatment by surgery on survival. Models were fit in both the full population and, separately, stratified by race/ethnicity and age at diagnosis (<40 vs. ≥40).Results:In adjusted models, age at diagnosis, CT-SES, and metastasis at diagnosis were associated with mortality. In race/ethnicity-stratified analysis, higher CT-SES was found to improve survival only in the White population. Among those diagnosed before age 40, metastasis at diagnosis and American Indian/Alaska Native race/ethnicity were associated with mortality, and both Hispanic ethnicity and Asian/Pacific Islander race were suggestive for increased mortality. Among cases, diagnoses at age 40 and above, age at diagnosis, male sex, and CT-SES were associated with mortality.Conclusions:This analysis provides evidence that among pediatric and young adult patients, non-White populations experience inferior survival compared with Whites, independent of CT-SES. Our findings also suggest that the effect of CT-SES on MPNST survival may differ by racial/ethnic group.Impact:These findings suggest that barriers to healthcare for certain racial/ethnic groups extend beyond SES.
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results–Based Analysis
Background:Recent investigations of malignant peripheral nerve sheath tumor (MPNST) survival have reported higher mortality among non-White individuals. However, previous analyses have not examined the impact of socioeconomic status (SES) on these observations. This study aims to characterize factors associated with cause-specific MPNST survival, including information related to census-tract-level SES (CT-SES).Methods:We identified 2,432 primary MPNSTs using the Surveillance, Epidemiology, and End Results (SEER) 18 (2000–2016) database. We used Cox proportional hazards modeling to estimate the effects of sex, race/ethnicity, CT-SES quintile, metastasis at diagnosis, tumor site, age at diagnosis, and treatment by surgery on survival. Models were fit in both the full population and, separately, stratified by race/ethnicity and age at diagnosis (<40 vs. ≥40).Results:In adjusted models, age at diagnosis, CT-SES, and metastasis at diagnosis were associated with mortality. In race/ethnicity-stratified analysis, higher CT-SES was found to improve survival only in the White population. Among those diagnosed before age 40, metastasis at diagnosis and American Indian/Alaska Native race/ethnicity were associated with mortality, and both Hispanic ethnicity and Asian/Pacific Islander race were suggestive for increased mortality. Among cases, diagnoses at age 40 and above, age at diagnosis, male sex, and CT-SES were associated with mortality.Conclusions:This analysis provides evidence that among pediatric and young adult patients, non-White populations experience inferior survival compared with Whites, independent of CT-SES. Our findings also suggest that the effect of CT-SES on MPNST survival may differ by racial/ethnic group.Impact:These findings suggest that barriers to healthcare for certain racial/ethnic groups extend beyond SES.
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Table S2. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Odds ratios (OR) and 95% confidence intervals (CI) for the association between an interquartile range increase in PM2.5 and childhood cancer risk, per pregnancy period, mutually adjusted for NDVI.
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Odds ratios (OR) and 95% confidence intervals (CI) for the association between an interquartile range increase in PM2.5 and childhood cancer risk, per pregnancy period, mutually adjusted for NDVI.
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Table S4. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Odds ratios (OR) and 95% confidence intervals (CI) for the association between an interquartile range increase in the average normalized difference vegetation index (NDVI) and childhood cancer risk, per pregnancy period.
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Odds ratios (OR) and 95% confidence intervals (CI) for the association between an interquartile range increase in the average normalized difference vegetation index (NDVI) and childhood cancer risk, per pregnancy period.
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S2. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Annual maps of mean estimated PM2.5 values in Minnesota census tracts for the study period of 2000-2014. PM2.5 concentrations given in µg/m3 represent the average census tract-level exposure for study subjects in that tract during that year.
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Annual maps of mean estimated PM2.5 values in Minnesota census tracts for the study period of 2000-2014. PM2.5 concentrations given in µg/m3 represent the average census tract-level exposure for study subjects in that tract during that year.
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S4. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Density of study subjects in Minnesota census tracts. The top map represents density of cases and controls combined, while the lower left and lower right represent density of only controls and only cases, respectively.
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
Density of study subjects in Minnesota census tracts. The top map represents density of cases and controls combined, while the lower left and lower right represent density of only controls and only cases, respectively.
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S5. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
High and low average air pollution measured as the average of PM2.5 (µg/m3) and NDVI by cancer types, stratified by trimesters. Panel A: PM2.5 exposure; values < 12.0 µg/m3 were categorized as low and ≥12.0 were categorized as high. Panel B: NDVI exposure; values < 0.3 were categorized as low and ≥0.3 were categorized as high.
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
High and low average air pollution measured as the average of PM2.5 (µg/m3) and NDVI by cancer types, stratified by trimesters. Panel A: PM2.5 exposure; values < 12.0 µg/m3 were categorized as low and ≥12.0 were categorized as high. Panel B: NDVI exposure; values < 0.3 were categorized as low and ≥0.3 were categorized as high.
- Open Access
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Table S1. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
PM2.5 and NDVI exposure distribution between cases and controls per pregnancy period.
- 3 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1. from Ambient Fine Particulate Matter, Residential Greenness, and Childhood Cancer Risk by Trimester of Exposure in Minnesota 2000 to 2014: A Case–Control Study
PM2.5 and NDVI exposure distribution between cases and controls per pregnancy period.